Literature DB >> 21278590

Factors influencing laser peripheral iridotomy outcomes in white eyes: an anterior segment optical coherence tomography study.

Ghee Soon Ang1, Anthony P Wells.   

Abstract

PURPOSE: To determine the pre-laser anterior segment optical coherence tomography (AS-OCT) features in White eyes which may predict the outcome after laser peripheral iridotomy (PI). PATIENTS AND METHODS: Consecutive White patients who underwent laser PI at Capital Eye Specialists over a 25-month period (November 2007 to November 2009) were identified, and the AS-OCT images of the temporal and nasal angles (in light and dark) before laser were analyzed. The PI was considered unsuccessful if there was still iridotrabecular apposition in the dark in ≥2 quadrants at follow up. The parameters studied were anterior chamber depth, trabecular-iris angle (TIA), angle opening distance (AOD), trabecular-iris space area, trabecular-iris contact length (TICL), iris thickness, and maximum iris bow height (MIBH).
RESULTS: Images of 71 eyes (71 patients) were assessed. The mean age at laser PI was 60.3 (±10.0) years. The mean time from laser PI to the follow-up AS-OCT scan was 5.92 (±3.22) weeks. The TIA 500 (P=0.002 temporal; P=0.024 nasal), AOD 500 (P=0.004 temporal; P=0.022 nasal), and TICL (P<0.001 temporal; P=0.013 nasal) in light were significantly different between the successful and unsuccessful groups. The MIBH in light was significant temporally (P=0.021) and approached significance nasally (P=0.052). Iris thickness measurements demonstrated no statistical significance.
CONCLUSIONS: An unsuccessful PI outcome is associated with pre-laser greater angle closure (decreased TIA 500 and AOD 500, increased TICL) and less anterior iris bowing (decreased MIBH) in light conditions in the temporal and nasal angles.

Entities:  

Mesh:

Year:  2011        PMID: 21278590     DOI: 10.1097/IJG.0b013e3181f7b26f

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  8 in total

1.  Subsequent Receipt of Interventions for Glaucoma Among a Nationwide Sample of Patients Who Underwent Laser Peripheral Iridotomy.

Authors:  Surbhi Bansal; S Asha Balakrishnan; Taylor Blachley; Jennifer S Weizer; Paul P Lee; Joshua D Stein
Journal:  Am J Ophthalmol       Date:  2015-04-30       Impact factor: 5.258

2.  Role of lens vault in subtypes of angle closure in Iranian subjects.

Authors:  S Moghimi; Z Vahedian; N Zandvakil; M Mohammdi; G Fakhraie; N Nassiri; A L Coleman; S Lin
Journal:  Eye (Lond)       Date:  2014-01-10       Impact factor: 3.775

3.  Biometric indicators of anterior segment parameters before and after laser peripheral iridotomy by swept-source optical coherent tomography.

Authors:  Bo Yu; Kang Wang; Xiaomin Zhang; Xiaoli Xing
Journal:  BMC Ophthalmol       Date:  2022-05-16       Impact factor: 2.086

4.  Early phacoemulsification in patients with acute primary angle closure.

Authors:  Sasan Moghimi; Hesam Hashemian; Rebecca Chen; Mohammadkarim Johari; Massood Mohammadi; Shan C Lin
Journal:  J Curr Ophthalmol       Date:  2016-01-12

5.  Long-Term Effect of Early Phacoemulsification in Primary Angle Closure Glaucoma Patients with Cataract: A 10-Year Follow-Up Study.

Authors:  Hazem Helmy
Journal:  Clin Ophthalmol       Date:  2021-09-29

Review 6.  Changing trends of imaging in angle closure evaluation.

Authors:  Syril Dorairaj; James C Tsai; Tomas M Grippo
Journal:  ISRN Ophthalmol       Date:  2012-05-13

7.  Peripheral iris thickness and association with iridotrabecular contact after laser peripheral iridotomy in patients with primary angle-closure and primary angle-closure glaucoma.

Authors:  Takanori Mizoguchi; Mineo Ozaki; Harumi Wakiyama; Nobuchika Ogino
Journal:  Clin Ophthalmol       Date:  2014-03-11

Review 8.  Anterior Segment Optical Coherence Tomography Changes to the Anterior Chamber Angle in the Short-term following Laser Peripheral Iridoplasty.

Authors:  James Chiung Yoong Leong; Jeremy O'Connor; Ghee Soon Ang; Anthony P Wells
Journal:  J Curr Glaucoma Pract       Date:  2014-01-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.